Discovery of a Potent, Selective, and Orally Bioavailable Pyridinyl-Pyrimidine Phthalazine Aurora Kinase Inhibitor
- 4 August 2010
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (17), 6368-6377
- https://doi.org/10.1021/jm100394y
Abstract
The discovery of aurora kinases as essential regulators of cell division has led to intense interest in identifying small molecule aurora kinase inhibitors for the potential treatment of cancer. A high-throughput screening effort identified pyridinyl-pyrimidine 6a as a moderately potent dual inhibitor of aurora kinases -A and -B. Optimization of this hit resulted in an anthranilamide lead (6j) that possessed improved enzyme and cellular activity and exhibited a high level of kinase selectivity. However, this anthranilamide and subsequent analogues suffered from a lack of oral bioavailability. Converting the internally hydrogen-bonded six-membered pseudo-ring of the anthranilamide to a phthalazine (8a−b) led to a dramatic improvement in oral bioavailability (38−61%F) while maintaining the potency and selectivity characteristics of the anthranilamide series. In a COLO 205 tumor pharmacodynamic assay measuring phosphorylation of the aurora-B substrate histone H3 at serine 10 (p-histone H3), oral administration of 8b at 50 mg/kg demonstrated significant reduction in tumor p-histone H3 for at least 6 h.Keywords
This publication has 33 references indexed in Scilit:
- Through the “Gatekeeper Door”: Exploiting the Active Kinase ConformationJournal of Medicinal Chemistry, 2009
- Type-II Kinase Inhibitor Docking, Screening, and Profiling Using Modified Structures of Active Kinase StatesJournal of Medicinal Chemistry, 2008
- Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinaseProceedings of the National Academy of Sciences of the United States of America, 2007
- Evolution of a Highly Selective and Potent 2-(Pyridin-2-yl)-1,3,5-triazine Tie-2 Kinase InhibitorJournal of Medicinal Chemistry, 2007
- An Automated Screening Assay for Determination of Aqueous Equilibrium Solubility Enabling SPR Study During Drug Lead OptimizationSLAS Technology, 2005
- Aurora kinases in spindle assembly and chromosome segregationExperimental Cell Research, 2004
- The cellular geography of Aurora kinasesNature Reviews Molecular Cell Biology, 2003
- Synthesis of N-Phenylanthranilic Acid Derivatives Using Water as Solvent in the Presence of Ultrasound IrradiationSynthetic Communications, 2003
- A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancersThe EMBO Journal, 1998
- Measurement and Analysis of Unbound Drug ConcentrationsClinical Pharmacokinetics, 1996